DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Cellularline S.p.A.

BIT:CELL Stock Report

Market Cap: €56.8m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Cellularline Future Growth

Future criteria checks 3/6

Cellularline is forecast to grow earnings and revenue by 154.6% and 1.5% per annum respectively.

Key information

154.6%

Earnings growth rate

n/a

EPS growth rate

Tech earnings growth85.4%
Revenue growth rate1.5%
Future return on equityn/a
Analyst coverage

Low

Last updated16 Sep 2026

Recent future growth updates

Recent updates

Analysis Article • Mar 19

Cellularline (BIT:CELL) Is Increasing Its Dividend To €0.093

The board of Cellularline S.p.A. ( BIT:CELL ) has announced that it will be increasing its dividend by 6.9% on the 21st...
Analysis Article • May 10

Is Cellularline (BIT:CELL) Using Too Much Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • May 25

Is Cellularline (BIT:CELL) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Apr 29

At €4.58, Is Cellularline S.p.A. (BIT:CELL) Worth Looking At Closely?

While Cellularline S.p.A. ( BIT:CELL ) might not be the most widely known stock at the moment, it had a relatively...
Analysis Article • Apr 04

Some Investors May Be Worried About Cellularline's (BIT:CELL) Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Analysis Article • Mar 14

Do Institutions Own Cellularline S.p.A. (BIT:CELL) Shares?

Every investor in Cellularline S.p.A. ( BIT:CELL ) should be aware of the most powerful shareholder groups...
Analysis Article • Feb 21

Does Cellularline's (BIT:CELL) Statutory Profit Adequately Reflect Its Underlying Profit?

Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...
Analysis Article • Feb 06

A Look At The Intrinsic Value Of Cellularline S.p.A. (BIT:CELL)

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Cellularline S.p.A...
Analysis Article • Jan 21

Is There Now An Opportunity In Cellularline S.p.A. (BIT:CELL)?

Cellularline S.p.A. ( BIT:CELL ), might not be a large cap stock, but it saw a double-digit share price rise of over...
Analysis Article • Jan 06

Should You Buy Cellularline S.p.A. (BIT:CELL) For Its Dividend?

Is Cellularline S.p.A. ( BIT:CELL ) a good dividend stock? How can we tell? Dividend paying companies with growing...
Analysis Article • Dec 22

Reflecting on Cellularline's (BIT:CELL) Share Price Returns Over The Last Year

Investors can approximate the average market return by buying an index fund. While individual stocks can be big...
Analysis Article • Dec 11

How Much Of Cellularline S.p.A. (BIT:CELL) Do Insiders Own?

Every investor in Cellularline S.p.A. ( BIT:CELL ) should be aware of the most powerful shareholder groups. Generally...
Analysis Article • Nov 29

Not Many Are Piling Into Cellularline S.p.A. (BIT:CELL) Just Yet

When close to half the companies in Italy have price-to-earnings ratios (or "P/E's") above 19x, you may consider...

Earnings and Revenue Growth Forecasts

BIT:CELL - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202716059141
12/31/2026157410151
6/30/2026157-351318N/A
3/31/2026157-361318N/A
12/31/2025157-361419N/A
9/30/202516051419N/A
6/30/202516261520N/A
3/31/202516571419N/A
12/31/202416461622N/A
9/30/202416451824N/A
6/30/202416361924N/A
3/31/202416032025N/A
12/31/20231594813N/A
9/30/2023154-35611N/A
6/30/2023151-36-13N/A
3/31/2023145-7522N/A
12/31/2022138-7505N/A
9/30/2022132-4305N/A
6/30/2022125-4417N/A
3/31/2022117-328N/A
12/31/2021111-41419N/A
9/30/2021108151323N/A
6/30/2021108151727N/A
3/31/2021101121323N/A
12/31/202010514111N/A
9/30/202011871220N/A
6/30/2020122121319N/A
3/31/202014018N/A20N/A
12/31/201914018N/A20N/A
9/30/201913419N/A20N/A
6/30/201913622N/A34N/A
3/31/201910824N/A20N/A
12/31/20189432N/A13N/A
9/30/20188443N/AN/AN/A
6/30/201815237N/A1N/A
3/31/201814630N/A11N/A
12/31/201713924N/A21N/A
12/31/201615922N/A31N/A
12/31/20151579N/A21N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CELL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.4%).

Earnings vs Market: CELL is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: CELL is expected to become profitable in the next 3 years.

Revenue vs Market: CELL's revenue (1.5% per year) is forecast to grow slower than the Italian market (5.7% per year).

High Growth Revenue: CELL's revenue (1.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CELL's Return on Equity is forecast to be high in 3 years time


Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/21 22:31
End of Day Share Price 2026/09/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cellularline S.p.A. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrea BonfaBanca Akros S.p.A. (ESN)
Alberto FranceseIntesa Sanpaolo Equity Research
Gabriele BertiIntesa Sanpaolo Equity Research

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide